1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 1: Distribution of contrast enhancement in the AES in relation to clinical findings in 42 eyes with retinoblastoma^a
Variable Normal (n = 13) Moderate (n = 15) Strong (n = 14) P Value
Tumor recurrence 1.00
    Yes 0 (0) 1 (7) 0 (0) 
    No 13 (100) 14 (93) 14 (100) 
Intraocular pressure .61
    Unknown 9 (69) 7 (47) 4 (29) 
    Mean ± SD (mm Hg) 11.8 ± 5.7 24.1 ± 9.6 19.0 
    Range (mm Hg) 7–20 11–36 10–37 
Vitreous seeding .17
    Yes 3 (23) 8 (57) 7 (54) 
    No 10 (77) 6 (43) 6 (46) 
Subretinal seeding .31
    Yes 6 (46) 5 (36) 3 (23) 
    No 7 (54) 9 (64) 10 (77) 
Anterior chamber seeding 1.00
    Yes 0 (0) 1 (7) 0 (0) 
    No 13 (100) 14 (93) 14 (100) 
Anterior chamber depth .07
    Shallow 0 (0) 3 (20) 4 (29) 
    Normal 13 (100) 12 (80) 10 (71) 
Pseudohypopyon 1.00
    Yes 0 (0) 1 (7) 0 (0) 
    No 13 (100) 14 (93) 14 (100) 
Hyperemia .20
    Yes 0 (0) 4 (27) 3 (21) 
    No 13 (100) 11 (73) 11 (79) 
IA .20
    Yes 0 (0) 0 (0) 2 (14) 
    No 13 (100) 15 (100) 12 (86) 
a Unless otherwise indicated, data are the number of eyes, and numbers in parentheses are percentages.